Tricyclic guanidine derivatives as sodium-proton exchange inhibitors

Details for Australian Patent Application No. 2005303409 (hide)

Owner Piramal Life Sciences Limited

Inventors Lal, Bansi; Trivedi, Jacqueline; Jain, Arun Kumar; Bal-Tembe, Swati; Ghate, Anil; More, Tulsidas; Parikh, Sapna; Ghosh, Usha

Agent Shelston IP

Pub. Number AU-B-2005303409

PCT Pub. Number WO2006/051476

Priority 1225/MUM/2004 10.11.04 IN; 60/637,208 17.12.04 US

Filing date 8 November 2005

Wipo publication date 18 May 2006

Acceptance publication date 15 December 2011

International Classifications

C07D 327/08 (2006.01) Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms

A61K 31/382 (2006.01) - having six-membered rings, e.g. thioxanthenes

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

24 May 2007 PCT application entered the National Phase

  PCT publication WO2006/051476 Priority application(s): WO2006/051476

2 September 2010 Assignment before Grant

  Nicholas Piramal India Limited The application has been assigned to Piramal Life Sciences Limited

15 December 2011 Application Accepted

  Published as AU-B-2005303409

12 April 2012 Standard Patent Sealed

1 November 2012 Assignment Registered

  Piramal Life Sciences Limited The patent has been assigned to Piramal Enterprises Limited

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005303410-Fused tricyclic compounds as inhibitors of tumor necrosis factor-alpha

2005303398-Method for priority based queuing and assembling of packets